Cyclin E and FGF8 are downstream cell growth regulators in distinct tumor suppressor effects of ANXA7 in hormone-resistant cancer cells of breast versus prostate origin.

Bera, A; Leighton, X-M; Pollard, H; Srivastava, M

Bera, A; Leighton, X-M; Pollard, H; Srivastava, M.

Afiliação

Bera A; Department of Anatomy, Physiology and Genetics, and Institute for Molecular Medicine, Uniformed Services University of Health Sciences (USUHS) School of Medicine, Bethesda, MD 20814, USA.
Leighton XM; Department of Anatomy, Physiology and Genetics, and Institute for Molecular Medicine, Uniformed Services University of Health Sciences (USUHS) School of Medicine, Bethesda, MD 20814, USA.
Pollard H; Department of Anatomy, Physiology and Genetics, and Institute for Molecular Medicine, Uniformed Services University of Health Sciences (USUHS) School of Medicine, Bethesda, MD 20814, USA.
Srivastava M; Department of Anatomy, Physiology and Genetics, and Institute for Molecular Medicine, Uniformed Services University of Health Sciences (USUHS) School of Medicine, Bethesda, MD 20814, USA.

Trends Cancer Res ; 13: 55-62, 2018.

Article em En | MEDLINE | ID: mdl-30369774

Palavras-chave

annexin A7; cyclin E; fibroblast growth factor 8 (FGF8); prostate and breast cancer; tumor suppression

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2018 Tipo de documento: Article